- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Mar 31, 2024 | 58.08M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $0 |
| Capex | Q1 2024 · Mar 31, 2023 | $0 |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $64.24K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $57.7K |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $64.24K |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $57.7K |
| Current Assets | Q1 2024 · Mar 31, 2024 | $0 |
| Current Assets | Q1 2024 · Dec 31, 2023 | $0 |
| Total Assets | Q1 2024 · Mar 31, 2024 | $0 |
| Total Assets | Q1 2024 · Dec 31, 2023 | $0 |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 58.02M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$33.72K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $876 |
| Cash And Equivalents | Q1 2024 · Dec 31, 2022 | $754 |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$42.48K |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$8.77K |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$0.00 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$0.00 |
| Net Income | Q1 2024 · Mar 31, 2023 | −$33.72K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$33.72K |
| Revenue | Q1 2024 · Mar 31, 2023 | $0 |